TAM
CLBT icon

Thematics Asset Management’s Cellebrite CLBT Stock Holding History

Thematics Asset Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$19.8M Buy
1,066,850
+196,924
+23% +$3.09M 0.9% 43
2025
Q2 		$13.9M Buy
+869,926
New +$15.5M 0.63% 61

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Thematics Asset Management's CLBT Position: Q3 2025 in Review

Thematics Asset Management increased its Cellebrite (CLBT) stake by 23% in Q3 2025, buying an estimated $3.09M and bringing the position to 1,066,850 shares worth $19.8M. The position accounts for 0.9% of the portfolio, ranked #43.

Thematics Asset Management first reported a position in CLBT in Q2 2025 and has held it in 2 quarters since. 196 funds tracked by Wall St. Rank hold CLBT as of Q3 2025.

  • Thematics Asset Management held 1,066,850 shares of Cellebrite worth $19.8M as of Q3 2025.
  • Thematics Asset Management bought 196,924 Cellebrite shares in Q3 2025, an estimated $3.09M.
  • Cellebrite made up 0.9% of Thematics Asset Management's portfolio in Q3 2025, its #43 holding.
  • Thematics Asset Management first reported a position in Cellebrite in Q2 2025 and has held it in 2 quarters since.
  • 196 funds tracked by Wall St. Rank held Cellebrite as of Q3 2025.

Based on Thematics Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.